Copeland Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-35,160
Closed -$2.91M 133
2017
Q1
$2.91M Sell
35,160
-452
-1% -$35.6K 0.2% 113
2016
Q4
$2.56M Buy
35,612
+804
+2% +$58.1K 0.17% 118
2016
Q3
$2.7M Sell
34,808
-1,041
-3% -$84.1K 0.17% 113
2016
Q2
$2.8M Sell
35,849
-779
-2% -$62.1K 0.19% 107
2016
Q1
$3M Sell
36,628
-302
-0.8% -$24.6K 0.21% 104
2015
Q4
$3.3M Sell
36,930
-256,547
-87% -$21.8M 0.19% 107
2015
Q3
$22.5M Buy
293,477
+20,336
+7% +$1.7M 1.38% 21
2015
Q2
$22.8M Sell
273,141
-1,712
-0.6% -$151K 1.17% 22
2015
Q1
$24.8M Sell
274,853
-71
-0% -$6.11K 1.65% 7
2014
Q4
$22.2M Sell
274,924
-13,490
-5% -$1.07M 1.61% 14
2014
Q3
$21.6M Buy
288,414
+24,167
+9% +$1.76M 2.2% 6
2014
Q2
$18.1M Buy
264,247
+42,126
+19% +$2.87M 2.02% 12
2014
Q1
$15.5M Sell
222,121
-20,773
-9% -$1.44M 1.89% 21
2013
Q4
$16.2M Sell
242,894
-18,326
-7% -$1.12M 2.12% 10
2013
Q3
$13.6M Buy
261,220
+7,063
+3% +$359K 2.12% 17
2013
Q2
$12M Buy
+254,157
New +$11.6M 2.16% 16

Other funds holding CAH

Copeland Capital Management's CAH Position: Q2 2017 in Review

Copeland Capital Management sold out of Cardinal Health (CAH) in Q2 2017, closing a stake of 35,160 shares — an estimated $2.91M sold.

Copeland Capital Management first reported a position in CAH in Q2 2013 and held it in 16 quarters. The position peaked at $24.8M in Q1 2015. 747 funds tracked by Wall St. Rank hold CAH as of Q2 2017.

  • Copeland Capital Management reported no remaining Cardinal Health position as of Q2 2017 after selling out during the quarter.
  • Copeland Capital Management sold 35,160 Cardinal Health shares in Q2 2017, an estimated $2.91M.
  • Copeland Capital Management first reported a position in Cardinal Health in Q2 2013 and held it in 16 quarters.
  • Copeland Capital Management's Cardinal Health position peaked at $24.8M in Q1 2015.
  • 747 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2017.

Based on Copeland Capital Management's 13F filing for Q2 2017, filed 21 Jul 2017.